Cargill signs up to patsystems

This deal is viewed as important given patsystems’ strategic review in January, when it said it would renegotiate a ‘significant’ number of existing contracts with clients in a drive towards profitability. The decision to renegotiate contracts led to some industry concern about the long-term viability of the company.

CIS - a futures, options, foreign exchange and over-the-counter derivatives broker - is a wholly owned subsidiary of Cargill, and offers clearing, execution and related client services to institutional customers.

“We aim to go live with the first part of the installation before the end of Q1 this year,” said patsystems’ chief executive, David Jones. “Initially we will offer CIS connectivity to six global exchanges,” he added.

Although Jones remained tight-lipped about the size and specifics of the agreement, he did indicate that the CIS contract was "substantial" and would be determined by performance based on contract volumes, technical support and ongoing installations.

“Patsystems’ browser-based trading systems will allow our customers to log-on and trade from anywhere at anytime,” said CIS vice-president and chief technology officer, Dale Martin.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Next-generation technologies and the future of trading

At a Risk.net webinar in association with capital markets technology provider Numerix, panellists discuss the potential for increased adoption of the public cloud to boost investment performance, its impact on risk management and overcoming barriers to…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here